Cell therapy biotech shifts focus to UK, makes deep cuts to US headcount
It’s been less than two months since Instil Bio revealed it would cut 60% of its US-based staff as the biotech scrapped its lead cell …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
